Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-01

Clinical Trial Update: Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating systemic exposure of Granexin Gel after topical application to venous leg ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Granexin Gel

Snippet

Sponsor: Xequel Bio, Inc. | Conditions: Venous Leg Ulcer | Phase 1 | Status: COMPLETED